Acute hepatitis C virus infection: A neglected disease?

Gut

Volumn 55, Issue 8, 2006, Pages 1075-1077

  Irving, W L ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONFIDENCE INTERVAL; GENOTYPE; HEALTH CARE POLICY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTIOUS HEPATITIS; META ANALYSIS; NOTE; PRIORITY JOURNAL; RISK FACTOR; SCHISTOSOMIASIS; SEX DIFFERENCE; SYSTEMATIC REVIEW; VIRUS INFECTION; VIRUS TRANSMISSION;

ACUTE DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; RNA, VIRAL; SEX FACTORS;

EID: 33746109029     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.085407     Document Type: Note

References (16)

1. Kamal SM, Amin A, Madwar M, et al. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 2004;78:12252-8.
2. Takoki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000;6:578-82.
3. Bakr I, Rekacewicz C, El Hosseiny M, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006;55:1183-7.
4. Aarons E, Grant P, Soldan K, et al. Failure to diagnose recent hepatitis C virus infections in London injecting drug users. J Med Virol 2004;73:548-53.
5. Beld M, Penning M, van Putten M, et al. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion. Blood 1999;94:1183-91.
6. Diepolder HM, Zachoval R, Hoffmann RM, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995;346:1006-7.
7. Hofer H, Watkins-Riedel T, Janata O, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003;37:60-4.
8. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006;13:34-41.
9. Larghi A, Zuin M, Crosignani A, et al. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002;36:993-1000.
10. Thomas DL, Astemborsk J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000;284:450-6.
11. Hwang SJ, Lee SD, Lu RH, et al. Hepatitis C viral genotype influences the clinical outcome or patients with acute posttransfusion hepatitis C. J Med Virol 2001;65:505-9.
12. Minton EJ, Smillie D, Neal KR, et al. The MHC Class II alleles DRB1*11 and DQB1*0301 are associated with clearance of hepatitis C virus infection. J Infect Dis 1998;178:39-44.
13. Missale G, Bertoni R, Lamonaca V, et al. Different clinical behaviours of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-14.
14. Al-Sherbiny M, Osman A, Mohamed N, et al. Exposure to hepatitis C virus induces cellular immune responses without detectable viraemia or seroconversion. Am J Trop Med Hyg 2005;73:44-9.
15. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-7.
16. Sypsa V, Touloumi G, Tassopoulos NC, et al. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends in cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. J Viral Hep 2004;11:366-74.